Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets.
about
DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus.Update on B-cell targeted therapies for systemic lupus erythematosus.Current role of rituximab in systemic lupus erythematosus.Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
P2860
Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Aberrant B-lymphocyte response ...... potential therapeutic targets.
@en
type
label
Aberrant B-lymphocyte response ...... potential therapeutic targets.
@en
prefLabel
Aberrant B-lymphocyte response ...... potential therapeutic targets.
@en
P2093
P2860
P356
P1476
Aberrant B-lymphocyte response ...... potential therapeutic targets.
@en
P2093
Asad Rahim
Fabian Flores-Borja
Hawzheen A Muhammad
Rizgar A Mageed
Taher E Taher
P2860
P304
P356
10.1111/ECI.12111
P577
2013-05-23T00:00:00Z